Inflammation-Related Gene Polymorphisms Associated With Primary Immune Thrombocytopenia
Ju Li,Sai Ma,Linlin Shao,Chunhong Ma,Chengjiang Gao,Xiao-hui Zhang,Ming Hou,Jun Peng
DOI: https://doi.org/10.3389/fimmu.2017.00744
IF: 7.3
2017-06-28
Frontiers in Immunology
Abstract:Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease characterized by a reduced platelet count and an increased risk of bleeding. Although immense research has improved our understanding of ITP, the pathogenesis remains unclear. Here, we investigated the involvement of 25 single-nucleotide polymorphisms (SNPs) of the inflammation-related genes, including <i>CD24, CD226, FCRL3, IL2, IRF5, ITGAM, NLRP3, CARD8, PTPN22, SH2B2, STAT4, TNFAIP3</i>, and <i>TRAF1</i>, in the pathogenesis and treatment response of ITP. We recruited 312 ITP inpatients and 154 healthy participants in this case-control study. Inflammation-related SNP genotyping was performed on the Sequenom MassARRAY iPLEX platform. The expression of TNFAIP3 mRNA was determined by quantitative real-time RT-PCR. All SNPs in healthy controls were consistent with Hardy-Weinberg equilibrium. Statistical analysis revealed that rs10499194 in <i>TNFAIP3</i> was significantly associated with a decreased risk of ITP after Bonferroni multiple correction (codominant, CT vs. CC, OR = 0.431, 95% CI = 0.262-0.711, <i>p</i> = 0.001; dominant, TT/CT vs. CC, OR = 0.249, 95% CI = 0.141-0.440, <i>p</i> = 0.000). Besides, <i>TNFAIP3</i> expression was significantly higher in patients with CT and pooled CT/TT genotypes compared with CC genotype (<i>p</i> = 0.001; <i>p</i> = 0.001). Interestingly, rs10499194 was also associated with corticosteroid-sensitivity (codominant, CT vs. CC, OR = 0.092, 95% CI = 0.021-0.398, <i>p</i> = 0.001; dominant, TT/CT vs. CC, OR = 0.086, 95% CI = 0.020-0.369, <i>p</i> = 0.001; allelic, T vs. C, OR = 0.088, 95% CI = 0.021-0.372, <i>p</i> = 0.001). Furthermore, no significant association was found between inflammation-related SNPs and the severity or refractoriness of ITP after Bonferroni multiple correction. Our findings suggest that rs10499194 may be a protective factor for susceptibility and corticosteroid sensitivity in ITP patients.
immunology